M3, Inc. provides medical-related services primarily to physicians and other healthcare professionals through Internet. More Details
No risks detected for MTHR.F from our risk checks.
Flawless balance sheet with high growth potential.
Share Price & News
How has M3's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: MTHR.F has not had significant price volatility in the past 3 months.
7 Day Return
US Healthcare Services
1 Year Return
US Healthcare Services
Return vs Industry: Insufficient data to determine how MTHR.F performed against the US Healthcare Services industry.
Return vs Market: Insufficient data to determine how MTHR.F performed against the US Market.
Price Volatility Vs. Market
How volatile is M3's share price compared to the market and industry in the last 5 years?
Simply Wall St News
No news available
Is M3 undervalued compared to its fair value and its price relative to the market?
Price to Earnings (PE) ratio
Share Price vs. Fair Value
Below Fair Value: MTHR.F ($60.28) is trading above our estimate of fair value ($14.2)
Significantly Below Fair Value: MTHR.F is trading above our estimate of fair value.
Price To Earnings Ratio
PE vs Industry: MTHR.F is poor value based on its PE Ratio (189x) compared to the US Healthcare Services industry average (63.7x).
PE vs Market: MTHR.F is poor value based on its PE Ratio (189x) compared to the US market (17.6x).
Price to Earnings Growth Ratio
PEG Ratio: MTHR.F is poor value based on its PEG Ratio (8.2x)
Price to Book Ratio
PB vs Industry: MTHR.F is overvalued based on its PB Ratio (26.3x) compared to the US Healthcare Services industry average (5.2x).
How is M3 forecast to perform in the next 1 to 3 years based on estimates from 13 analysts?
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: MTHR.F's forecast earnings growth (23% per year) is above the savings rate (2.2%).
Earnings vs Market: MTHR.F's earnings (23% per year) are forecast to grow faster than the US market (22.9% per year).
High Growth Earnings: earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: MTHR.F's revenue (16.8% per year) is forecast to grow faster than the US market (9.9% per year).
High Growth Revenue: MTHR.F's revenue (16.8% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: MTHR.F's Return on Equity is forecast to be high in 3 years time (20%)
How has M3 performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: MTHR.F has high quality earnings.
Growing Profit Margin: MTHR.F's current net profit margins (17.1%) are higher than last year (17%).
Past Earnings Growth Analysis
Earnings Trend: MTHR.F's earnings have grown by 14.2% per year over the past 5 years.
Accelerating Growth: MTHR.F's earnings growth over the past year (16.7%) exceeds its 5-year average (14.2% per year).
Earnings vs Industry: MTHR.F earnings growth over the past year (16.7%) exceeded the Healthcare Services industry -4.8%.
Return on Equity
High ROE: MTHR.F's Return on Equity (15%) is considered low.
How is M3's financial position?
Financial Position Analysis
Short Term Liabilities: MTHR.F's short term assets (¥116.6B) exceed its short term liabilities (¥34.8B).
Long Term Liabilities: MTHR.F's short term assets (¥116.6B) exceed its long term liabilities (¥13.6B).
Debt to Equity History and Analysis
Debt Level: MTHR.F is debt free.
Reducing Debt: MTHR.F had no debt 5 years ago.
Debt Coverage: MTHR.F has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: MTHR.F has no debt, therefore coverage of interest payments is not a concern.
What is M3 current dividend yield, its reliability and sustainability?
Current Dividend Yield
Dividend Yield vs Market
Notable Dividend: MTHR.F's dividend (0.13%) isn’t notable compared to the bottom 25% of dividend payers in the US market (1.72%).
High Dividend: MTHR.F's dividend (0.13%) is low compared to the top 25% of dividend payers in the US market (4.94%).
Stability and Growth of Payments
Stable Dividend: MTHR.F is not paying a notable dividend for the US market, therefore no need to check if payments are stable.
Growing Dividend: MTHR.F is not paying a notable dividend for the US market, therefore no need to check if payments are increasing.
Current Payout to Shareholders
Dividend Coverage: MTHR.F is not paying a notable dividend for the US market.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of MTHR.F's dividend in 3 years as they are not forecast to pay a notable one for the US market.
How experienced are the management team and are they aligned to shareholders interests?
Average board tenure
Itaru Tanimura (55 yo)
Mr. Itaru Tanimura has been the President of M3, Inc. since September 2000. Mr. Tanimura was Partner/Joint Manager of McKinsey & Co. since December 1999. He Joined McKinsey & Co. in April 1987. He has been ...
|President & Representative Director||20yrs||no data||2.86% |
|Director||8.25yrs||no data||0.065% |
|External Director||20yrs||no data||no data|
|Director||6.25yrs||no data||0.10% |
|Director||4.25yrs||no data||0.0038% |
|Director||2.17yrs||no data||0.0016% |
|Director||1.67yrs||no data||no data|
|Independent Director||1.67yrs||no data||no data|
|Director||1.67yrs||no data||no data|
Experienced Board: MTHR.F's board of directors are considered experienced (4.3 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
M3, Inc.'s company bio, employee growth, exchange listings and data sources
- Name: M3, Inc.
- Ticker: MTHR.F
- Exchange: OTCPK
- Founded: 2000
- Industry: Health Care Technology
- Sector: Healthcare
- Market Cap: JP¥4.384t
- Listing Market Cap: JP¥41.502b
- Shares outstanding: 678.64m
- Website: https://corporate.m3.com
Number of Employees
- M3, Inc.
- Akasaka Intercity
- 10th Floor
|Ticker||Exchange||Primary Security||Security Type||Country||Currency||Listed on|
|MTHR.F||OTCPK (Pink Sheets LLC)||Yes||Common Stock||US||USD||Sep 2004|
|2413||TSE (The Tokyo Stock Exchange)||Yes||Common Stock||JP||JPY||Sep 2004|
|2413 N||BMV (Bolsa Mexicana de Valores)||Yes||Common Stock||MX||MXN||Sep 2004|
|MTHR.Y||OTCPK (Pink Sheets LLC)||UNSPON ADR||US||USD||Mar 2020|
M3, Inc. provides medical-related services primarily to physicians and other healthcare professionals through Internet. The company operates m3.com, a members-only Web site for providing information to the ...
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2020/09/27 06:20|
|End of Day Share Price||2020/09/24 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.